Vitamin C Supplementation in Hereditary Hemochromatosis

Primary Contraindication

The American Association for the Study of Liver Diseases recommends that vitamin C supplements should be avoided during treatment of hereditary hemochromatosis, as pharmacologic doses of vitamin C accelerate iron mobilization to levels that may saturate circulating transferrin, resulting in increased pro-oxidant and free-radical activity, particularly in iron-loaded patients undergoing phlebotomy 1, 2, 3
Cardiac dysrhythmias and cardiomyopathy are the most common causes of sudden death in iron overload states, and this risk increases during rapid iron mobilization, with supplemental vitamin C posing a serious risk of accelerated iron mobilization leading to cardiac complications and sudden death 1, 2, 3, 4, 5

In iron-overloaded patients with thalassemia major, oral vitamin C supplementation has been associated with acute deterioration of cardiac function due to iron mobilization from reticuloendothelial stores, increased iron availability, and free radical generation, highlighting the danger of vitamin C in iron overload 2
Case reports have documented that high-dose oral vitamin C can accelerate iron deposition and favor deterioration of heart disease in severe hemochromatosis, emphasizing the need for caution with vitamin C supplementation in these patients 2

The European Association for the Study of the Liver recommends that supplemental vitamin C should be avoided, especially before iron depletion, with the American Association for the Study of Liver Diseases stating that vitamin C supplements should be avoided during treatment of hereditary hemochromatosis 1, 2
For patients receiving iron chelators, vitamin C intake should not exceed 200 mg daily, as recommended by hepatology guidelines 3, 4, 5

If vitamin C supplementation is absolutely necessary for other medical reasons in a hemochromatosis patient who has achieved iron depletion, it should be limited to 500 mg daily maximum and only after physician discussion, applying to patients who have completed iron depletion therapy, have serum ferritin maintained at target levels, and are without cardiac complications 1, 2

Dietary modifications are not required for vitamin C-containing foods, with the concern being specifically about supplemental/pharmacologic doses of vitamin C, not dietary sources, and fruit juices and citrus fruits should be consumed in moderation and not in combination with iron-rich foods 1, 2

All hemochromatosis patients with elevated ferritin or undergoing phlebotomy should avoid all vitamin C supplements, with patients on iron chelation therapy limiting total vitamin C intake to ≤200 mg daily, and patients who have achieved iron depletion and require vitamin C for other conditions taking a maximum of 500 mg daily after physician consultation 1, 2, 3, 4, 5